4min chapter

Multiple Myeloma Hub cover image

What are the pros and cons of bispecific antibodies for multiple myeloma?

Multiple Myeloma Hub

CHAPTER

Comparing CARTY Cells and Bi-specific Antibodies in Multiple Myeloma Treatment

Speakers discuss the effectiveness and considerations of CARTY cells versus bi-specific antibodies for multiple myeloma patients, highlighting the evolving landscape of therapies and emphasizing the importance of individualized patient choices.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode